Efficacy and safety of Alitretinoin versus Cyclosporine A in patients with moderate-to-severe chronic hand eczema (ALICsA): a randomised, open-label trial with blinded outcome assessment (EADV 2026) - Aug 6, 2026 - Abstract #P1565; Pres time: Sep 30, 2026; Location: ePoster Area; No abstract available
Clinical • Atopic Dermatitis • Contact Dermatitis • Dermatology • Immunology
|